Trials / Completed
CompletedNCT00733200
Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 26 Years – 72 Years
- Healthy volunteers
- Not accepted
Summary
The investigators conducted a prospective study to determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in 138 patients with hilar cholangiocarcinoma. In selected patients, minor liver resection was a good treatment.
Detailed description
Objective: To determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in patients with hilar cholangiocarcinoma (HC). Summary Background Data: For HC treated with hepatectomy, the extent of liver resection remains controversial despite extensive studies. Methods: From January 2000 to December 2007, we prospectively studied patients who received surgical treatment for HC. Of the 187 patients who were surgically treated, 138 (73.8%) underwent resection with a curative intent. Minor hepatectomy was carried out in 93 patients who had Bismuth-Corlette types I, II and III HC without hepatic artery/portal vein invasion; and major hepatectomy in 45 patients who had type III HC with hepatic artery/portal vein invasion, or type IV HC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Minor or Major Liver Resection |
Timeline
- First posted
- 2008-08-12
- Last updated
- 2009-12-11
Source: ClinicalTrials.gov record NCT00733200. Inclusion in this directory is not an endorsement.